(NP (-LRB- -LCB-) (NP (DT The) (NNS changes)) (PP (IN in) (NP (NP (NN glucocorticoid) (NNS receptors)) (PP (IN in) (NP (NP (JJ peripheral) (NNS leukocytes)) (PP (IN in) (NP (JJ asthmatic) (NNS subjects))))))) (-RRB- -RCB-))
(S (NP-SBJ-1 (NP (DT The) (NN number)) (PP (IN of) (NP (NP (NP (NN glucocorticoid) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NN GCR)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ peripheral) (NNS leukocytes)))))) (VP (VBD was) (VP (VBN determined) (NP (-NONE- *-1)) (PP (IN by) (NP (JJ radioligand-binding) (NN assay))) (PP (IN in) (NP (ADJP-COOD (ADJP (JJ extrinsic)) (CC and) (ADJP (JJ intrinsic))) (NNS asthmatics))))) (. .))
(S (NP-SBJ-2 (PRP$ Their) (JJ corresponding) (NN plasma) (NN cortisol) (NNS levels)) (VP (VBD were) (VP (VBN assessed) (NP (-NONE- *-2)))) (. .))
(S (NP-SBJ (DT The) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S-COOD (S (NP-SBJ (NP (DT the) (JJ average) (NN number)) (PP (IN of) (NP (NP (NN GCR)) (PP (IN in) (NP (NNS asthmatics)))))) (VP (VBD was) (ADJP-PRD (ADJP (RB significantly) (JJR lower)) (PP (IN than) (NP (NP (DT that)) (PP (IN in) (NP (JJ healthy) (NNS subjects)))))) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN P)) (NP-PRD (QP (JJR &lt;) (CD 0.01)))) (-RRB- -RRB-)))) (, ,) (CC and) (S (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (DT a) (JJ linear) (NN correlation)) (PP (IN between) (NP-COOD (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN GCR)))) (CC and) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (NN asthma)))))))))))) (. .))
(S (ADVP (RB Besides)) (, ,) (NP-SBJ (EX there)) (VP (VBD was) (ADVP (RB also)) (NP-PRD (NP (DT a) (JJ linear) (NN correlation)) (PP (IN between) (NP-COOD (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN GCR)))) (CC and) (NP (NP (DT the) (NN age)) (PP (IN of) (NP (NP (DT the) (JJ initial) (NN attack)) (PP (IN of) (NP (NN asthma)))))))))) (. .))
(S (NP-SBJ-3 (NP (DT No) (NN difference)) (PP (IN in) (NP (NN plasma) (NN cortisol) (NN level)))) (VP (VBD was) (VP (VBN found) (NP (-NONE- *-3)) (PP (IN between) (NP-COOD (NP (NNS asthmatics)) (CC and) (NP (JJ healthy) (NNS subjects)))))) (. .))
(S (NP-SBJ (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S-COOD (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (DT no) (ADJP-COOD (ADJP (JJ primary)) (CC and) (ADJP (JJ general))) (NN impairment)) (PP (IN of) (NP (NN glucocorticoid) (NN metabolism)))) (PP (IN in) (NP (DT the) (NNS asthmatics))))) (, ,) (CC but) (S (NP-SBJ (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NN GCR)) (PP (IN in) (NP (DT the) (NNS asthmatics)))))) (VP (VBZ is) (ADJP-PRD (ADJP (JJR lower)) (PP (IN than) (NP (NP (DT that)) (PP (IN in) (NP (JJ healthy) (NNS controls))))))))))) (. .))
(S-4 (NP-SBJ (NP (DT The) (NN decrease)) (PP (IN of) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NN GCR)) (PP (IN in) (NP (NNS asthmatics)))))))) (PRN (, ,) (S (NP-SBJ (PRP we)) (VP (VBP think) (S (-NONE- *T*-4)))) (, ,)) (VP (VBZ is) (ADJP-PRD (JJ related) (PP (TO to) (NP-COOD (NP (NN heredity)) (CC and) (NP (NP (VBN repeated) (NNS attacks)) (PP (IN of) (NP (NN asthma)))))))) (. .))
